$SRNE Several institutional investors and hedge funds have recently modified their holdings of the stock. Patriot Financial Group Insurance Agency LLC purchased a new stake in shares of Sorrento Therapeutics during the second quarter worth approximately $25,000. Valeo Financial Advisors LLC purchased a new stake in Sorrento Therapeutics in the 2nd quarter valued at $25,000. Focused Wealth Management Inc grew its holdings in Sorrento Therapeutics by 50.0% in the 2nd quarter. Focused Wealth Management Inc now owns 12,000 shares of the biopharmaceutical company’s stock valued at $75,000 after buying an additional 4,000 shares in the last quarter. Centaurus Financial Inc. grew its holdings in Sorrento Therapeutics by 21.7% in the 1st quarter. Centaurus Financial Inc. now owns 28,000 shares of the biopharmaceutical company’s stock valued at $52,000 after buying an additional 5,000 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in Sorrento Therapeutics
  • 11
11 Likes